Ester Lozano

7PUBLICATIONS
37CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiologyMedical infection agents (incl. prions)Medical mycologyTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2025
Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited.

Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol

|Aug 10, 2024
Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV.

Sergio Barroso, Mariona Guitart-Mampel, Francesc Josep García-García

|Jul 11, 2024
Increased PVR Expression on Bone Marrow Macrophages May Promote Resistance to TIGIT Blockade in Multiple Myeloma.

Ester Lozano, Mari-Pau Mena, Glòria Garrabou

|Aug 27, 2021
Two Novel Variants in YARS2 Gene Are Responsible for an Extended MLASA Phenotype with Pancreatic Insufficiency.

Lidia Carreño-Gago, Diana Luz Juárez-Flores, Josep Maria Grau

|Jun 10, 2020
Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma.

Ester Lozano, Mari-Pau Mena, Tania Díaz

|Mar 14, 2018
Loss of the Immune Checkpoint CD85j/LILRB1 on Malignant Plasma Cells Contributes to Immune Escape in Multiple Myeloma.

Ester Lozano, Tania Díaz, Mari-Pau Mena

Pageof 2